EMAIL THIS PAGE TO A FRIEND

The Prostate

Bone marrow-derived cells contribute to regeneration of injured prostate epithelium and stroma.


PMID 25663042

Abstract

Recent studies have reported that bone marrow-derived cells (BMDCs), which are recruited to sites of tissue injury and inflammation, can differentiate into epithelial cells, such as liver, lung, gastrointestinal tract, and skin cells. We investigated the role of BMDCs in contributing to regeneration of injured prostate epithelium. Using chimera rats that received allogenic bone marrow grafts from green fluorescent protein (GFP) transgenic rats after lethal whole-body irradiation, we investigated the existence of epithelial marker-positive BMDCs in injured prostate tissue caused by transurethral injection of lipopolysaccharide. Prostate tissues were harvested 2 weeks after transurethral lipopolysaccharide injection. Immunofluorescence staining showed that some cells in the stroma co-expressed GFP and pan-cytokeratin, which suggested the existence of epithelial marker-positive BMDCs. To confirm the existence of such cells, we collected bone marrow-derived non-hematopoietic cells (GFP+/CD45- cells) from the prostate by fluorescence-activated cell sorter analysis and analyzed the characteristics of the GFP+/CD45- cells. The number of cells in this population significantly increased from 0.042% to 0.492% compared with normal prostate tissue. We found by immunofluorescent analysis and RT-PCR that GFP+/CD45- cells expressed cytokeratin, which suggested that these cells have some features of epithelial cells. In the prostate obtained from the chimera rats 34 weeks after lipopolysaccharide injection, GFP- and cytokeratin-positive cells were observed in the prostate gland, which suggested that some of the cells in the prostate gland regenerated after prostate inflammation derived from bone marrow. BMDCs might be able to differentiate into prostate epithelial cells after prostatic injury.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB1409018
Anti-AKR1B1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB2100091
Anti-AKR1B1 antibody produced in rabbit, affinity isolated antibody
SAB4500944
Anti-AKR1B1, C-Terminal antibody produced in rabbit, affinity isolated antibody
GW22855 Anti-Amphiregulin antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
SAB1405478
Anti-AREG antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB1410727
Anti-AREG antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
SAB1400100
Anti-FDXR antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB1400101
Anti-FDXR antibody produced in mouse, IgG fraction of antiserum, buffered aqueous solution
SAB2100807
Anti-FDXR antibody produced in rabbit, affinity isolated antibody
SAB1402112
Monoclonal Anti-AKR1B1 antibody produced in mouse, clone 2D12, purified immunoglobulin, buffered aqueous solution
WH0000367M1
Monoclonal Anti-AR antibody produced in mouse, clone 1G3, purified immunoglobulin, buffered aqueous solution
SAB5300341 Monoclonal Anti-AR antibody produced in mouse, clone 1A9D12, ascites fluid
SAB5300342
Monoclonal Anti-AR antibody produced in mouse, clone 2H8, ascites fluid
SAB1402118
Monoclonal Anti-AREG antibody produced in mouse, clone 3E4, purified immunoglobulin, buffered aqueous solution